Market Context — Why This Technology, Why Now

The pharmaceutical and healthcare sectors face immense pressure to enhance patient safety, reduce adverse drug events, and optimize treatment efficacy. Regulatory bodies are increasingly scrutinizing drug safety profiles, while competitive dynamics push for faster, more efficient drug development. This technology offers a critical tool for both clinical practice and R&D, enabling proactive risk management and supporting the global shift towards value-based care and precision medicine, which is projected to grow at an 18.5% CAGR.

Key Competitive Advantages
01

Achieves significantly higher side effect prediction accuracy compared to conventional empirical methods or single-data approaches.

02

Supports personalized treatment plan development by meticulously analyzing individual patient data, moving beyond uniform risk assessments.

03

Reduces unnecessary hospitalizations and additional treatments by predicting severe side effect risks proactively, improving healthcare economics and patient QOL.

Market Opportunity
Medical Institutions
$650M globally (AI est.)
With an aging population and increasing chronic diseases, optimal drug treatment and side effect management tailored to each patient's condition are essential. This technology provides individualized optimization, meeting the needs of medical institutions.
Large hospital networks Regional healthcare systems Specialized clinics
Pharmaceutical Companies
$200B globally (AI est.)
In the clinical trial phase of new drug development, early and highly accurate prediction of side effect risks contributes to trial efficiency and safety improvement. This could shorten development periods and reduce costs.
Global pharmaceutical R&D divisions Biotech firms developing novel drugs Contract Research Organizations (CROs)
Insurance & Healthcare Services
$150B globally (AI est.)
From the perspective of health management and preventive medicine, personalized drug risk assessment based on the insured's health status contributes to insurance premium design and service improvement, creating new added value.
Health insurance providers Digital health platform developers Corporate wellness program providers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects an information processing system that uses multi-dimensional feature vectors of drug, patient, and time information to predict side effects. With 8 broadly and precisely defined claims, it offers strong protection for its core prediction algorithm and method, having demonstrated objective uniqueness and inventiveness against four prior art references during examination.

Competitive White Space

This patent primarily protects the prediction model. White space exists in developing novel drug delivery systems based on these predictions or integrating with real-time biometric feedback devices for automated intervention.

Economic Impact
~$1.0M/year estimated medical cost and burden reduction potential per facility (est.).
estimated ROI · USD · AI analysis
ROI Calculation Logic

Estimates economic benefits by avoiding increased hospitalizations, prolonged treatments, and outpatient visits due to drug side effects. For example, if a drug with a 5% side effect risk is prescribed to 50,000 people annually, and this technology reduces side effect incidence by ~20%. Assuming an average medical cost increase of $2,000 (AI est.) per side effect case, the potential annual medical cost reduction is calculated as: 50,000 people × 5% × 20% × $2,000 = $1.0M (AI est.). Indirect benefits like reduced patient burden and improved QOL are also expected.

Speed to Market
6× faster than in-house development
This technology is an information processing program that handles drug, patient, and time data. The core prediction algorithm is presumed to be established. Therefore, system integration can be relatively quick if APIs are designed for linkage with existing medical information systems. No extensive hardware development or manufacturing processes are required, as the focus is primarily on software development and data integration, potentially shortening development time by ~2.5 years compared to developing equivalent technology in-house from scratch.
Competitive Positioning

X: Degree of Individual Optimization
Y: Prediction Accuracy

Business Models & Applications
🏥 SaaS-based Side Effect Prediction Service
Offer this technology as a cloud-based SaaS for healthcare institutions. This subscription model allows physicians to access real-time side effect predictions during prescription or follow-up.
🔗 API Integration Licensing
Provide the prediction API of this technology to electronic health record systems and pharmaceutical R&D platforms. This enables seamless integration and functional expansion for existing systems.
🔬 Data Analysis and Collaborative Research
Partner with pharmaceutical companies and research institutions to offer joint research and data analysis services for specific drug side effect profiling and risk assessment in new drug development.
Adjacent Application Opportunities
💊 製薬・臨床開発
Clinical Trial Optimization Support
This technology could significantly reduce new drug development time and costs by accurately predicting drug side effect risks during clinical trial phases. This enables optimized trial design and efficient subject selection, leading to earlier market entry for safer and more effective drugs.
🧬 遺伝子医療・個別化医療
Genetic Data-Driven Personalized Diagnostics
By integrating biological information, such as genetic and genomic data, into the multi-dimensional feature vector, this technology could support more personalized drug selection and administration plans. This holds the potential to realize truly individualized drug therapy tailored to each patient.
🧑‍⚕️ 遠隔医療・ホームヘルスケア
Remote Monitoring for Proactive Intervention
Applicable to remote monitoring systems that track real-time patient vital signs and medication adherence to identify early side effect risks and prompt preventive intervention. This could enhance medical safety and quality in home healthcare and elderly care settings.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: System Analysis and Data Integration Design
Duration: 5 months
Analyze the adopting company's current medical information systems and design data integration interfaces for this technology. Define necessary data items and formats, and consider privacy protection measures.
Phase 2: Model Adjustment and System Development
Duration: 8 months
Based on the design, adjust the prediction model to the adopting company's data. Concurrently, develop systems and APIs that allow physicians to visually confirm prediction results.
Phase 3: Clinical Pilot and Validation
Duration: 5 months
Conduct a pilot implementation in selected clinical departments or hospitals to verify prediction accuracy and physician usability in real-world operations. Measure effectiveness and make final adjustments for full deployment.
Technical Feasibility
This technology is centered on a prediction model using drug, patient, and time information as features, allowing for easy data linkage design with existing electronic health record (EHR) systems and prescription support systems. Specifically, the 'reception unit for input information' and 'output unit for expression information' are designed for API-based connections, enabling rapid deployment through software integration rather than extensive system modifications.
Success Scenario
If adopted, this technology could enable physicians to access real-time, personalized side effect probability during drug administration planning. This is estimated to reduce severe side effects by ~20% and improve patient treatment adherence by 15%. Ultimately, this could enhance patient QOL and optimize healthcare costs.
Patent Record
APPLICATION NO.
特願2020-104416
REGISTRATION NO.
7513254
FILING DATE
2020年06月17日
GRANT DATE
2024年07月01日
EXPIRATION DATE
2040年06月17日
PATENT HOLDER
国立大学法人　東京大学
Examination History
2023年05月11日
出願審査請求書
2024年06月05日
特許査定